Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine
Recruiting
Observational Study
Monkeypox
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 90 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is to evaluate the long-term immunogenicity of a boost dose of MVA-BN vaccine
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men aged over 18 years
* Have received two doses of MVA-BN vaccine as an initial schedule
* Eligible for a booster dose of MVA-BN (according to the HAS recommendation)
* Be eligible and wish to initiate PrEP-HIV treatment or be followed for PrEP-HIV treatment
* Covered by soci…
Contacts